Delivery Order SPE2DB20D1047-SPE2DB23FF53B
Award Date
3/20/23
Potential Completion Date
3/21/23
Potential Value
$5.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,707.34 firm-fixed-price delivery order is for the pharmaceutical product LINZESS 145 MCG CAPSULE. The contract has an ultimate completion date of October 21, 2021. This appears to be part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $8,069.09 firm fixed-price delivery order contract is for the supply of LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC enables the efficient...
This federal contract award, with an ID of SPE2DB22D1041|SPE2DB23FP5TD, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,786.85 firm fixed-price delivery order is for the supply of LINZESS 145 MCG capsules. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary...
This federal contract award, valued at $2,918.33, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of LINZESS 72 MCG Capsule, a pharmaceutical product, with a completion date of May 15, 2023. The contract is an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award, with the ID SPE2DB20D3101|SPE2DB22FK4R2, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of the pharmaceutical product LINZESS 290 MCG CAPSULE UU 30S, with a total ceiling value of $1,855.16 and a completion date of July 26, 2022. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $2,411.52, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the medication LINZESS 290 MCG CAPSULE UU 30S, with a period of performance through November 30, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a separate $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $1,184.61, is a Firm Fixed Price Delivery Order for the supply of the prescription medication LINZESS 72 MCG CAPSULE. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $1,550.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of LINZESS 145 MCG CAPSULE UU 30S, a pharmaceutical product. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary...
The federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of LINZESS 145 MCG CAPSULE UU 30S. The fixed-price delivery order, valued at $1,308.75, has a completion date of November 30, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which...
This federal contract award, valued at $20,956.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product. This is a firm fixed-price delivery order with an ultimate completion date of October 30, 2023. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...